BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10680467)

  • 1. [Radioiodine therapy of benign thyroid disease in Denmark].
    Rasmussen AK; Jarløv AE; Faber J
    Ugeskr Laeger; 2000 Jan; 162(3):327-30. PubMed ID: 10680467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
    Kobe C; Eschner W; Wild M; Rahlff I; Sudbrock F; Schmidt M; Dietlein M; Schicha H
    Nucl Med Commun; 2010 Mar; 31(3):201-5. PubMed ID: 19907353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Need for thyroidectomy in patients treated with radioactive iodide for benign thyroid disease.
    Villadsen MJ; Sørensen CH; Godballe C; Nygaard B
    Dan Med Bull; 2011 Dec; 58(12):A4343. PubMed ID: 22142572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unsuccessful radioiodine treatment of a non-toxic goiter: a case report.
    Hartoft-Nielsen ML; Rasmussen AK; Friis E; Blichert-Toft M; Buhl T; Hesse B; Feldt-Rasmussen U
    Basic Clin Pharmacol Toxicol; 2004 Aug; 95(2):72-5. PubMed ID: 15379783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
    Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
    Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Graves' disease nd toxic nodular goiter--radioiodine therapy].
    Schicha H; Dietlein M
    Nuklearmedizin; 2002 Apr; 41(2):63-70. PubMed ID: 11989300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Can radioactive iodine be used in the treatment of diffuse non-toxic goiter?].
    Nygaard B; Hegedüs L; Bennedbaek FN; Veje A; Faber JO; Hansen JE
    Ugeskr Laeger; 1998 Sep; 160(37):5349-52. PubMed ID: 9748860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapy.
    Kahraman D; Keller C; Schneider C; Eschner W; Sudbrock F; Schmidt M; Schicha H; Dietlein M; Kobe C
    Clin Endocrinol (Oxf); 2012 Feb; 76(2):297-303. PubMed ID: 21854403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radioiodine treatment of benign thyroid diseases].
    Konrády A
    Orv Hetil; 2006 Sep; 147(37):1783-9. PubMed ID: 17131798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of Basedow disease after radioiodine therapy for nodular goiter].
    Cseke B; Balázs C
    Orv Hetil; 2003 Nov; 144(47):2327-9. PubMed ID: 14725052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External dose rates in radioiodine treatment of benign goitre: estimation versus direct measurement.
    Jørgensen HB; Høilund-Carlsen PF; Nielsen VE
    Scand J Clin Lab Invest; 2006; 66(6):509-16. PubMed ID: 17000558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH).
    Bonnema SJ; Nielsen VE; Hegedüs L
    Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of large multinodular goitre using repeated doses of radioiodine.
    Baczyk M; Pisarek M; Czepczyński R; Ziemnicka K; Gryczyńska M; Pietz L; Sowiński J
    Nucl Med Commun; 2009 Mar; 30(3):226-31. PubMed ID: 19262285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term effect of 131I therapy of multinodular non-toxic goiter].
    Nygaard B; Hegedüs L; Gervil M; Jensen HH; Søe-Jensen P; Hansen JE
    Ugeskr Laeger; 1994 Sep; 156(39):5699-703. PubMed ID: 7985257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of iodine application during radioiodine therapy in patients with impending therapy failure].
    Urbannek V; Schmidt M; Moka D; Hillger HW; Voth E; Wellner U; Schicha H
    Nuklearmedizin; 2000; 39(4):108-12. PubMed ID: 10919161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioiodine therapy of thyroid autonomy.
    Reiners C; Schneider P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine therapy for thyroid volume reduction of large goitres.
    Bachmann J; Kobe C; Bor S; Rahlff I; Dietlein M; Schicha H; Schmidt M
    Nucl Med Commun; 2009 Jun; 30(6):466-71. PubMed ID: 19381116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of radioiodine therapy in benign nodular goitre.
    Bonnema SJ; Fast S; Hegedüs L
    Best Pract Res Clin Endocrinol Metab; 2014 Aug; 28(4):619-31. PubMed ID: 25047210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.